Cytolytic Vaginosis: When Lactobacillus May Be Linked to Thrush-Like Symptoms

If you keep experiencing vaginal burning, itching or white discharge, but repeated thrush treatments don't seem to help, there may be another explanation worth considering.

One possibility is cytolytic vaginosis (CV).

Cytolytic vaginosis is a proposed and increasingly recognised cause of vulvovaginal symptoms characterised by abundant Lactobacillus, epithelial cell cytolysis and a relatively low vaginal pH.

It can look remarkably similar to vulvovaginal candidiasis (thrush), which is one reason women with persistent symptoms may receive repeated antifungal treatment before another explanation is considered.

However, there is an important qualification.

Cytolytic vaginosis remains incompletely understood.

Although it was described in the medical literature more than 30 years ago and continues to be investigated, there is currently no universally accepted diagnostic gold standard, and the quality of evidence surrounding its prevalence, diagnosis and treatment remains limited.

A 2023 scoping review of 64 publications found significant knowledge gaps across essentially all areas of cytolytic vaginosis research. The authors concluded that further research is needed to establish its validity and ensure women are diagnosed and treated appropriately.

More recent studies continue to identify a recognisable cytolytic pattern in some symptomatic women, suggesting that CV deserves consideration — particularly when symptoms resemble thrush but Candida testing is repeatedly negative.

The important point isn't that every woman with recurrent thrush-like symptoms has cytolytic vaginosis.

It's that persistent symptoms deserve an accurate diagnosis rather than repeated treatment based on symptoms alone.

What Is Cytolytic Vaginosis?

The vagina normally contains many different microorganisms.

In many reproductive-aged women, Lactobacillus species are an important component of a healthy vaginal microbiome.

They contribute to vaginal acidity through the production of lactic acid and help create an environment that can inhibit the growth of some potentially harmful organisms.

So Lactobacillus is generally something we want to see.

Cytolytic vaginosis challenges the simplistic idea that: more Lactobacillus must always be better.

CV was described by Cibley and Cibley in 1991 as a condition associated with symptoms including vulval itching, painful intercourse, vulval dysuria and cyclical symptoms, together with abundant lactobacilli and evidence of epithelial cytolysis on microscopy.

Cytolysis refers to disruption or fragmentation of vaginal epithelial cells.

Under microscopy, this may appear as:

• fragmented epithelial cells

• cytoplasmic debris

• free or “naked” nuclei

• abundant Lactobacillus

• relatively few white blood cells

Importantly, these findings are different from simply having a Lactobacillus-dominant vaginal microbiome.

A woman can have abundant Lactobacillus without necessarily having cytolytic vaginosis.

That distinction matters.

Is Cytolytic Vaginosis a Proven Medical Condition?

This deserves a direct answer.

Cytolytic vaginosis has been described in the medical literature for decades, but significant scientific uncertainty remains.

The original diagnostic criteria were proposed in 1991. Subsequent observational studies have identified similar patterns in women with vulvovaginal symptoms.

However, the 2023 scoping review found that much of the available literature consisted of reviews and observational studies, with substantial variation in how CV was diagnosed.

There remains:

• no universally accepted diagnostic gold standard

• uncertainty about true prevalence

• limited evidence regarding causation

• limited high-quality treatment research

• uncertainty about how CV relates to different Lactobacillus species and other vaginal conditions

The review found a median reported prevalence of approximately 5% among symptomatic women across the more informative prevalence studies, but estimates varied considerably.

Some newer individual studies have reported substantially higher prevalence within selected populations presenting with vaginitis. That does not mean that one-third or one-fifth of all women with vaginal symptoms have CV; differences in populations and diagnostic definitions matter.

For this reason, I prefer to describe the clinical approach to CV as evidence-informed.

It is something worth considering when the clinical and laboratory pattern fits — without treating every Lactobacillus-dominant result as disease.

Why Is Cytolytic Vaginosis Often Confused With Thrush?

This is probably the most clinically important issue.

Both cytolytic vaginosis and vulvovaginal candidiasis can present with symptoms such as:

• vaginal or vulval itching

• burning

• irritation

• white discharge

• discomfort during sex

• external burning when passing urine

Symptoms alone therefore cannot reliably distinguish the two.

In candidiasis, appropriate microscopy, culture or molecular testing may demonstrate Candida.

In reported cases of CV, microscopy instead demonstrates abundant lactobacilli together with epithelial fragmentation/cytolysis, while fungal elements are absent.

This distinction becomes particularly relevant when someone has repeatedly been told they have “thrush” based largely on symptoms but:

• Candida testing remains negative

• antifungal treatment doesn't provide sustained improvement

• symptoms repeatedly return

• vaginal pH remains acidic

• Lactobacillus is very abundant

• microscopy demonstrates epithelial cytolysis

That doesn't automatically prove CV.

But it is a reason to reconsider the diagnosis.

What Are the Symptoms of Cytolytic Vaginosis?

Reported symptoms include:

• vulval itching

• burning

• vaginal or vulval irritation

• white or increased vaginal discharge

• discomfort during intercourse

• external dysuria

• recurrent “thrush-like” symptoms

Some studies have also described a cyclical pattern, with symptoms occurring more commonly or becoming more noticeable during the ovulatory or luteal phases of the menstrual cycle.

However, no symptom pattern is diagnostic by itself.

That's important because discharge, itching and burning occur across many different vulvovaginal conditions.

Does Cytolytic Vaginosis Get Worse Before Your Period?

Some women described in the CV literature experience cyclical symptoms.

The original Cibley description reported symptoms becoming more pronounced during the luteal phase, and subsequent research has also found clustering of symptoms during ovulatory and luteal phases in some women with CV.

That makes menstrual timing potentially useful information during assessment.

But I would not say: “It gets worse before my period” = cytolytic vaginosis.

Thrush and other vulvovaginal conditions can fluctuate across the menstrual cycle as well.

The pattern is a clue, not a diagnosis.

What Vaginal pH Is Associated With Cytolytic Vaginosis?

CV has traditionally been associated with an acidic vaginal environment.

The original proposed diagnostic criteria described vaginal pH of approximately: 3.5–4.5

This is very different from bacterial vaginosis, where vaginal pH is commonly above 4.5.

An important nuance is that an acidic pH is not abnormal by itself.

A healthy reproductive-aged vagina is normally acidic.

Likewise, vulvovaginal candidiasis generally occurs while vaginal pH remains within the acidic range.

So: Low vaginal pH does not diagnose cytolytic vaginosis.

It needs to be interpreted alongside symptoms and microscopy/cytological findings.

Can You Have “Too Much” Lactobacillus?

A Lactobacillus-dominant vaginal microbiome is generally associated with vaginal health.

Therefore:

Finding lots of Lactobacillus does not automatically mean something is wrong.

What distinguishes proposed CV from ordinary Lactobacillus dominance is the combination of symptoms + abundant Lactobacillus + epithelial cytolysis + exclusion of more established causes of symptoms.

Research has also begun investigating whether particular Lactobacillus species or microbial characteristics are associated with CV.

The 2023 scoping review noted that Lactobacillus crispatus frequently dominated reported CV microbial communities.

That does not mean L. crispatus is inherently harmful.

L. crispatus is commonly associated with a healthy vaginal microbiome.

Rather, it reinforces the importance of interpreting microbiome results in context instead of classifying individual organisms as simply “good” or “bad.”

Do Probiotics Cause Cytolytic Vaginosis?

There isn't enough evidence to say that Lactobacillus probiotics cause cytolytic vaginosis.

This is an area where online information often gets ahead of the science.

If someone with suspected CV is using:

• vaginal Lactobacillus probiotics

• oral Lactobacillus probiotics

• vaginal products intended to increase Lactobacillus

it is reasonable to review whether continued supplementation is appropriate.

But that is different from claiming that probiotics caused the condition.

At present, evidence establishing probiotic supplementation as a cause of CV is limited.

How Is Cytolytic Vaginosis Diagnosed?

There is currently no universally accepted diagnostic gold standard.

Traditionally, assessment has relied on the combination of symptoms, vaginal pH and microscopic findings.

The original proposed criteria included:

• symptoms compatible with vulvovaginal irritation

• vaginal pH approximately 3.5–4.5

• abundant Lactobacillus

• evidence of epithelial cytolysis

• relatively few white blood cells

• absence of Candida

• absence of Trichomonas

• absence of findings consistent with bacterial vaginosis

Later studies have similarly identified abundant lactobacilli, fragmented epithelial cells/free nuclei and absence of fungal growth as useful findings when distinguishing CV from candidiasis.

A 2025 study found epithelial cytolysis and false clue cells to be particularly specific within its study population, although these findings still require validation in broader populations.

Why Microscopy Matters

This is one situation where simply knowing which bacteria are present may not answer the entire question.

Cytolysis is a cellular finding.

Microscopy or appropriately interpreted Gram-stained vaginal samples can demonstrate:

• epithelial fragmentation

• naked nuclei

• cytoplasmic debris

• abundant lactobacilli

• inflammatory cells

• Candida morphology where present

• clue-cell patterns associated with BV

This can provide information that microbial detection alone cannot.

A routine vaginal swab might report “normal vaginal flora” or Lactobacillus predominance.

That result isn't necessarily incorrect.

It simply may not answer the question:

Are the vaginal epithelial cells undergoing cytolysis?

What About Comprehensive Vaginal Microbiome Testing?

Comprehensive molecular vaginal microbiome testing can provide additional information about the microbial community.

Depending on the panel, this may include:

• Lactobacillus abundance

• Lactobacillus species

• BV-associated organisms

• aerobic organisms

• Candida species

• selected sexually transmitted infections

• other potentially relevant microorganisms

That can be particularly useful when someone has persistent or recurrent symptoms and previous testing has not explained the pattern.

However:

Molecular microbiome testing does not diagnose cytolytic vaginosis by itself.

A molecular test can tell us about microbial composition.

It cannot demonstrate epithelial cytolysis.

When CV is genuinely suspected, the most informative assessment may therefore involve combining:

symptoms + clinical history + vaginal pH + appropriate standard testing + microscopy/Gram staining where available + molecular microbiome information where clinically useful.

And, as with all microbiome testing:

Detection does not equal disease.

A high abundance of Lactobacillus — even L. crispatus — should not automatically be treated.

Cytolytic Vaginosis vs Thrush vs Bacterial Vaginosis

These conditions can produce overlapping symptoms, but the underlying patterns differ.

Is Cytolytic Vaginosis the Same as Vaginal Lactobacillosis?

Not necessarily.

The terminology surrounding Lactobacillus-associated vaginal conditions has historically been inconsistent.

Cytolytic vaginosis refers to the proposed syndrome characterised particularly by epithelial cytolysis associated with abundant Lactobacillus.

Other Lactobacillus-associated patterns described in the literature may have different microscopic appearances and should not automatically be grouped together.

This is another reason why saying “too much Lactobacillus” is not enough to make a diagnosis.

Morphology and the overall clinical picture matter.

How Is Cytolytic Vaginosis Treated?

There is currently no universally established treatment protocol for cytolytic vaginosis.

Historically, the most commonly described approach has been temporary alkalinisation of the vaginal environment using sodium bicarbonate.

The rationale is to temporarily raise vaginal pH and alter the environment associated with excessive Lactobacillus and cytolysis.

The original 1991 description recommended sodium bicarbonate treatment. However, the 2023 scoping review concluded that recommendations for bicarbonate treatment had historically been based largely on expert opinion rather than high-quality treatment trials.

There is now some additional observational evidence.

A clinicopathological study involving 53 women diagnosed with CV reported significant improvement in discharge, discomfort and dyspareunia following a standardised sodium bicarbonate sitz-bath regimen.

More recently, a prospective diagnostic study reported symptom relief in 58.8% of treated CV patients using sodium bicarbonate sitz baths. The authors emphasised that the treatment group was small and that larger studies and better treatment protocols are still required.

Research is also investigating other bicarbonate formulations, but these remain experimental rather than established clinical treatments.

This is why diagnosis matters before treatment.

Repeatedly attempting to alkalinise the vagina without establishing why symptoms are occurring could potentially delay diagnosis of Candida, BV, an STI, a vulval condition or another cause of symptoms.

Should You Stop Antifungal Treatment?

If candidiasis has not been demonstrated and repeated antifungal treatment isn't helping, the diagnosis deserves reconsideration.

Antifungals treat fungal infection.

They do not treat epithelial cytolysis or Lactobacillus-associated CV.

That doesn't mean every woman with persistent symptoms should simply stop prescribed medication on the basis of an internet article.

It means that repeated empirical antifungal treatment without confirmation of the diagnosis may not be the best approach to recurrent symptoms.

Should You Stop Vaginal Probiotics?

This also requires individual interpretation.

If testing and microscopy suggest CV and you are using Lactobacillus-containing vaginal products, continuing to deliberately increase vaginal Lactobacillus may not make clinical sense while the picture is being clarified.

However, evidence that probiotics cause or perpetuate CV remains limited.

I would therefore frame this as: review probiotic use rather than automatically assuming probiotics are responsible.

When Should Cytolytic Vaginosis Be Considered?

CV may be worth considering when there is a combination of:

• recurrent thrush-like symptoms

• repeated negative Candida testing

• little or no response to appropriate antifungal treatment

• acidic vaginal pH

• abundant Lactobacillus

• microscopy showing epithelial cytolysis

• cyclical symptoms in some women

No single feature confirms the diagnosis.

The more important message is:

If treatment keeps failing, reassess what is actually being treated.

What Else Can Cause Persistent Thrush-Like Symptoms?

Cytolytic vaginosis is only one possibility.

Persistent itching, burning, discharge or vulvovaginal discomfort can also occur with:

• recurrent vulvovaginal candidiasis

• non-albicans Candida

• bacterial vaginosis

• aerobic vaginitis

• sexually transmitted infections

• irritant or allergic contact dermatitis

• vulval dermatological conditions

• Genitourinary Syndrome of Menopause

• vulvodynia and other pain conditions

• other vulvovaginal disorders

This is why persistent symptoms sometimes require physical examination, microscopy, culture, STI testing, specialist assessment or other investigations rather than increasingly broad treatment.

When Should You See a GP or Sexual Health Clinician?

Telehealth can be useful for reviewing recurrent symptoms, previous pathology, treatment response, vaginal pH patterns and vaginal microbiome results.

However, suspected CV may require investigations that cannot be performed remotely.

You may be advised to see your GP, sexual health clinician, gynaecologist or another appropriate clinician for:

• vaginal examination

• vulval examination

• vaginal microscopy or Gram staining

• Candida microscopy/culture or speciation

• STI testing

• assessment of persistent skin changes

• investigation when the diagnosis remains unclear

Seek prompt medical assessment for significant pelvic or abdominal pain, fever or systemic illness, unexplained vaginal bleeding, new ulcers or lesions, rapidly worsening symptoms, or concerning symptoms during pregnancy.

A More Evidence-Informed Way to Think About Cytolytic Vaginosis

Cytolytic vaginosis is a fascinating example of why the vaginal microbiome cannot be reduced to:

Lactobacillus = good and everything else = bad.

The vaginal ecosystem is more complex.

At the same time, we shouldn't move too far in the opposite direction and assume that abundant Lactobacillus automatically represents disease.

The evidence currently supports a more nuanced position:

CV is a proposed and increasingly studied vulvovaginal condition associated with characteristic cytolytic findings, but important questions remain about its definition, prevalence, mechanisms and optimal treatment.

For women with persistent thrush-like symptoms, its greatest clinical relevance may be as a reminder to stop assuming that every episode of itching, burning and white discharge is Candida.

When symptoms keep returning, the goal should be to establish what is actually happening in the vaginal environment and choose treatment accordingly.

About Kylie Sayce NP

Kylie Sayce is an Australian Endorsed Nurse Practitioner with a clinical focus on recurrent vaginal and urinary conditions, vaginal microbiome health and women's sexual and reproductive health.

The Telehealth Clinic provides Australia-wide consultations for women experiencing recurrent BV, recurrent thrush, recurrent UTIs, aerobic vaginitis, persistent vaginal symptoms and vaginal microbiome disturbances.

For women with recurrent symptoms, consultations allow time to comprehensively review symptom patterns, previous pathology, treatment history, hormonal factors, vaginal pH where relevant and, where clinically appropriate, comprehensive vaginal microbiome testing.

My clinical approach is evidence-informed and focuses on understanding why symptoms are recurring rather than treating an isolated symptom or microbiome result in isolation.